Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Sep 17.
Published in final edited form as: Res Dev Disabil. 2012 Mar 22;33(4):1157–1168. doi: 10.1016/j.ridd.2012.01.004

Symptoms of autism and schizophrenia spectrum disorders in clinically referred youth with oppositional defiant disorder

Kenneth D Gadow a,*, Deborah AG Drabick b
PMCID: PMC3775839  NIHMSID: NIHMS511515  PMID: 22502841

Abstract

Examined autism spectrum disorder (ASD) and schizophrenia spectrum disorder (SSD) symptoms in a clinically referred, non-ASD sample (N = 1160; ages 6–18) with and without oppositional defiant disorder (ODD). Mothers and teachers completed DSM-IV-referenced symptom checklists. Youth with ODD were subdivided into angry/irritable symptom (AIS) or noncompliant symptom (NS) subtypes. Two different classification strategies were used: within-informant (source-specific) and between-informant (source-exclusive). For the source-specific strategy, youth were classified AIS, NS, or Control (C) according to mothers' and teachers' ratings separately. A second set of analyses focused on youth classified AIS according to mother or teacher report but not both (source-exclusive) versus both mother and teacher (cross-informant) AIS. Results indicated the mother-defined source-specific AIS groups generally evidenced the most severe ASD and SSD symptoms (AIS > NS > C), but this was more pronounced among younger youth. Teacher-defined source-specific ODD groups exhibited comparable levels of symptom severity (AIS, NS > C) with the exception of SSD (AIS > NS > C; younger youth). Source-exclusive AIS groups were clearly differentiated from each other, but there was little evidence of differential symptom severity in cross-informant versus source-exclusive AIS. These findings were largely dependent on the informant used to define the source-exclusive groups. AIS and NS groups differed in their associations with ASD and SSD symptoms. Informant discrepancy provides valuable information that can inform nosological and clinical concerns and has important implications for studies that use different strategies to configure clinical phenotypes.

Keywords: Oppositional defiant disorder, Autism spectrum disorder, DSM-5, Schizophrenia spectrum disorder, Anger, Irritability

1. Introduction

During the past decade, much progress has been made in conceptualizing emotional, behavioral, and cognitive disturbances among children with autism spectrum disorder (ASD) as co-occurring syndromes, many of which appear to share similarities in clinical features with psychiatric disorders defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994), though they are not necessarily clinically equivalent in terms of phenomenology, response to intervention, or natural history. This effort has been matched by an equally ambitious endeavor to examine ASD symptoms in nonASD, clinically referred, and population-based samples (e.g., Constantino & Todd, 2003; Gadow, DeVincent, Pomeroy, & Azizian, 2005; Kunihira, Senju, Dairoku, Wakabayashi, & Hasegawa, 2006; Posserud, Lundervold, & Gillberg, 2006; Reiersen, Constantino, Volk, & Todd, 2007; Ronald, Simonoff, Kuntsi, Asherson, & Plomin, 2008). The collective results of these and related efforts indicate that the phenotypic characteristics of psychiatric disorders are widely distributed in the general population and commonly co-occur in neurodevelopmental syndromes, which poses enormous challenges to the pursuit of more compelling models of nosology and pathogenesis.

One psychiatric syndrome of particular relevance for ASD is oppositional defiant disorder (ODD), which is characterized by angry and irritable affect and noncompliant behaviors. Collectively, the symptoms of ODD are (a) common reasons for clinical referral and personal and family distress for individuals with ASD, (b) the focus of much interest in pharmacotherapy (reviewed by Stigler & McDougle, 2008), and (c) the only Food and Drug Administration-approved indications for psychotropic medication among ASD individuals in the United States. Although figures vary, a substantial percentage of children with ASD meet DSM-IV diagnostic or symptom criteria for ODD (e.g., de Bruin, Ferdinand, Meester, de Nijs, & Verheij, 2007; Gadow et al., 2005; Simonoff et al., 2008; Witwer & Lecavalier, 2010) or evidence marked problems with specific symptoms such as irritability (Lecavalier, 2006; Mayes, Calhoun, Murray, Ahuja, & Smith, 2011). Some of these studies involve hundreds of youth with ASD, something almost unheard of just a decade ago.

Although research is limited, children with ASD plus ODD appear to differ in clinically important ways from youth with ASD who do not meet symptom criteria for ODD (Gadow, DeVincent, & Drabick, 2008). Moreover, there are similarities in associated clinical features of ODD among children with and without ASD, including (a) differentially more severe co-occurring psychiatric symptoms (Gadow, DeVincent, & Drabick, 2008) and sleep problems (DeVincent, Gadow, Delosh, & Geller, 2007) compared with peers without ODD; (b) informant discrepancies (mother versus teacher) in perceived symptom severity (Gadow, DeVincent, & Drabick, 2008); and (c) association with similar psychosocial and biological risk factors (e.g., Dean et al., 2010; Gadow, DeVincent, Olvet, Pisarevskaya, & Hatchwell, 2010; Gadow, DeVincent, & Schneider, 2008; Kirley et al., 2004). Although these consistencies support a “co-morbidity” interpretation, there are inconsistencies in the literature as well, and it is fair to say that the issue is far from being (if ever) resolved.

As for typically developing youth, a community-based study of preschoolers (Gadow & Nolan, 2002) found higher levels of ASD symptom severity among children who met symptom criteria for ODD versus peers who did not, and this was true for both mothers' and teachers' ratings. Similarly, Mulligan et al. (2009) examined a sample of 821 youth with attention-deficit/hyperactivity disorder (ADHD), their siblings, and controls, and found elevated levels of ASD severity in probands, with differentially higher levels in probands with ADHD plus ODD. Importantly, they also suggested that assessment of ASD symptoms at intake may be a useful indicator of risk for developing ODD or conduct disorder.

1.1. ODD and DSM-5

As with most psychiatric disorders, only a subset of symptoms is required for a diagnosis (polythetic criteria), and this inevitably results in phenotypic heterogeneity (Drabick, 2009; Sanislow et al., 2010). Given that angry/irritable symptoms (AIS) of ODD may contribute uniquely to the development of anxiety and mood disorders (Burke & Loeber, 2010; Burke, Hipwell, & Loeber, 2010; Leibenluft, Cohen, Gorrindo, Brook, & Pine, 2006; Rowe, Costello, Angold, Copeland, & Maughan, 2010; Stringaris & Goodman, 2009a, 2009b), the ADHD and Disruptive Behavior Disorders Workgroups for DSM-5 recommended organizing ODD symptoms within the DSM to distinguish between AIS and noncompliant symptoms (NS) (reviewed by Pardini, Frick, & Moffitt, 2010; www.dsm5.org). This is also relevant for the National Institute of Mental Health's (NIMH) recent Research Domain Criteria (RDoC) initiative, which identifies negative affect as one of its recognized domains (Sanislow et al., 2010). Our own prior research (Drabick & Gadow, 2012; Gadow & Drabick, submitted for publication) with the same large sample of clinically referred youth examined in the present study indicates that (a) individuals with ODD and more severe AIS differ in a number of ways from youth with primarily NS (Drabick & Gadow, 2012), and (b) youth whose AIS are essentially a problem at home but not school and vice versa are unique in a number of ways that suggest possible differences in pathogenesis (Gadow & Drabick, submitted for publication).

1.2. Schizophrenia spectrum disorder

Although child-onset schizophrenia is uncommon in ASD (reviewed by Starling & Dossetor, 2009), the symptoms of ASD and schizophrenia spectrum disorder (SSD) often co-occur (e.g., Sporn et al., 2004; Weisbrot, Gadow, DeVincent, & Pomeroy, 2005), are moderately to highly inter-correlated (e.g., Barneveld et al., 2011), and share pathogenic mechanisms (Cheung et al., 2010; Guilmatre et al., 2009; Kirov et al., 2008; Mikhail et al., 2011; Sahoo et al., 2011; Sebat, Levy, & McCarthy, 2009; Sugranyes, Kyriakopoulos, Corrigall, Taylor, & Frangou, 2011; Walsh et al., 2008). Thus, further study of their interrelation is warranted (Gadow & DeVincent, 2012). SSD symptoms are includedinthe present study given that both ASD and SSD are (a) characterized by social interaction deficits and (b) associated with emotion dysregulation (Gadow & DeVincent, 2012; Weisbrot et al., 2005).

1.3. Objectives

In spite of an intuitive overlap among disorders characterized by deficits in social interactions and emotion dysregulation, relatively little is known about ASD or SSD symptoms among youth with ODD, and more specifically, whether there is a differentially greater association with AIS or NS. The present study examined ASD and SSD symptom severity in a large sample (N = 1160) of clinically referred, non-ASD youth between 6 and 18 years of age. Although an alternative approach is to study these interrelations among youth with ASD, a compelling case also canbe made for such research in general population samples (e.g., Kelleher, Jenner, & Cannon, 2010; Whalley et al., 2011). Youth who met DSM-IV symptom criteria for ODD were subdivided into angry/irritable symptom (AIS) or noncompliant symptom (NS) subgroups. Youth with fewer than four ODD symptoms (the number of required symptoms in DSM-IV) served as Controls. Despite the relative absence of research in this area, we made the following predictions. We expected (1) more severe ASD symptoms among youth with ODD compared with Controls, with (2) differentially higher levels among youth with AIS versus NS (Drabick & Gadow, 2012). As ASD and SSD symptoms are interrelated (Gadow & DeVincent, 2012), we also expected (3) a similar pattern of relations for SSD symptoms.

There is relatively modest overlap among children that mothers and teachers characterize as ODD in both ASD (Gadow, DeVincent, & Drabick, 2008) and non-ASD (Drabick, Gadow, & Loney, 2007) samples. Thus, two different strategies for defining clinical phenotypes were examined. One set of analyses focused on within-informant group differences in youth classified AIS versus NS defined separately according to mothers' and teachers' ratings (source specificity) (Drabick et al., 2007; Drabick, Bubier, Chen, Price, & Lanza, 2011; Drabick & Gadow, 2012; Offord et al., 1996). For these source-specific analyses, we expected (4) greater AIS and NS group differences with teachers' than mothers' ratings (e.g., Dirks, Boyle, & Georgiades, 2011; Drabick et al., 2007, 2011). However, one potential limitation of this strategy is that youth with cross-informant AIS are included in both source-specific groups. Therefore, the second set of analyses focused on between-informant differences in youth classified AIS according to mother or teacher report but not both (source-exclusive) versus cross-informant (both mother and teacher) AIS (Drabick, Gadow, & Loney, 2008; Gadow & Drabick, submitted for publication). We expected (5) the source-exclusive (i.e., context bound) AIS groups to differ from each other because the grouping strategy maximizes informant disagreement. If cross-informant AIS represent a differentially more biologically impacted syndrome (see Gadow & Drabick, submitted for publication) or possibly a more homogeneous phenotype, then we would expect (6) the cross-informant group to have more severe co-occurring ASD and SSD symptoms (i.e., less contextually bound) than the source-exclusive groups. Finally, the facts that childhood-onset schizophrenia is rare and the peak ages of onset of psychosis are late adolescence and early adulthood (Paus, Keshavan, & Giedd, 2008) suggest that the severity of at least some SSD symptoms may change over time. Although there are some preliminary data among clinically referred youth to suggest this may not be the case for many SSD symptoms (e.g., Ulloa et al., 2000), we nevertheless expected (7) the pattern of differences in SSD symptom severity would vary for younger versus older ODD groups.

2. Materials and methods

2.1. Participants

Participants were parents (primarily mothers) and teachers of 1160 youth who were consecutive referrals to a university hospital child psychiatry outpatient service that serves an ethnically and economically diverse clientele. Given well-established developmental differences in the emergence of psychiatric symptomatology, we divided the sample into a younger (6–11 year olds; n = 546; 73% males) and older (12–18 year olds; n = 614; 67% males) cohort (full sample M = 12.1, SD = 3.4 years; 70% males). Caregiver-identified ethnicity was as follows: European-American (n = 977; 84%), African-American (n = 81; 7%), Hispanic-American (n = 127; 11%), Native-American (n = 12; 1%), Asian-American (n = 30; 3%), and Other (n = 11; 1%). Most (84%) youth lived with their biological mothers and fathers (62%), and in 65% of the cases, parents were married. The two most common clinician-assigned diagnoses were ADHD and ODD, and almost all youth with ODD were also co-morbid for ADHD. This retrospective chart review study was approved by a university Institutional Review Board, and appropriate measures were taken to protect patient (and rater) confidentiality.

2.2. Measures

Mothers and teachers rated youth's symptoms using the Child and Adolescent Symptom Inventory-4R (CASI-4R; Gadow & Sprafkin, 2005). The CASI-4R is a parent-(163-item) and teacher-(120-item) completed behavior rating scale for evaluating youth 5–18 years old and combines the symptom modules from the Child Symptom Inventory-4 (Gadow & Sprafkin, 1986, 2002) and the Adolescent Symptom Inventory-4 (Gadow & Sprafkin, 1995, 2008). Individual items bear one-to-one correspondence withDSM-IVsymptoms and are rated on a scale from 0 (never) to 3 (very often). Item responses were summed to create Symptom Severity scores for ASD and SSD symptoms. Research indicates the ASD subscale has relatively high sensitivity and specificity for identifying children with ASD (DeVincent & Gadow, 2009; Gadow, Schwartz, DeVincent, Strong, & Cuva, 2008). In the present study, Cronbach's alpha was high for both mother- and teacher-completed ASD severity scores (αs = 0.86 and 0.89, respectively). We also examined severity scores for each of the three core domains of ASD (4 items each) for mothers' and teachers' ratings, respectively: Communication Deficits (αs = 0.70, 0.74), Social Deficits (αs = 0.80, 0.84), and Perseverative Behaviors (αs = 0.68, 0.76). Findings from a number of studies support the divergent validity of the three core ASD domains (e.g., Gadow, DeVincent, & Pomeroy, 2006; Gadow, DeVincent, & Schneider, 2009; Gadow, Guttmann-Steinmetz, Rieffe, & DeVincent, 2011; Guttmann-Steinmetz, Gadow, DeVincent, & Crowell, 2010; Lecavalier, Gadow, DeVincent, Houts, & Edwards, 2009).

The SSD subscale (11 items) of the CASI-4R is comprised of the DSM-IV-defined symptoms of schizophrenia and schizoid personality disorder, two disorders that are phenomenologically and genetically related (Faridi, Pawliuk, King, Joober, & Malla, 2009; Mata et al., 2000). The findings from a number of studies indicate CASI-4R SSD component subscales demonstrate satisfactory internal consistency; convergent and discriminant validity with relevant measures; and agreement with structured interview or clinician diagnoses (e.g., Gadow & Sprafkin, 2002, 2008, 2010; Grayson & Carlson, 1991; Mattison, Gadow, Sprafkin, Nolan, & Schneider, 2003; Weisbrot et al., 2005). In the present study the internal reliabilities of the mother/teacher SSD subscale were high (αs = 0.84/0.88).

2.3. Procedure

Prior to scheduling their initial clinic evaluation, parents were mailed a packet of materials including behavior ratings scales for both parent and teacher, background information questionnaire, and permission for release of school, psychoeducational, and special education evaluation records. Teacher ratings were given to the school by parents, completed by teachers (96%), and mailed to the clinic prior to the evaluation. Youth with both parent and teacher reports (n = 1111) and youth with reports from only one informant (n = 49) did not differ on any categorical or dimensional ODD scores, ethnicity, family income, or parental education. However, compared to youth with one informant's report, youth with both informants' reports, respectively, were younger (Ms = 13.3 versus 12.0 years), more likely to be male (55% versus 70%), and more likely to have married parents (47% versus 66%).

2.4. Subgrouping

The present study builds on previous research using a priori operationalized criteria for AIS and NS as proposed for DSM-5. For both subgrouping strategies, youth with severity ratings of often or very often for “loses temper,” “is angry and resentful,” and “is touchy or easily annoyed by others” were placed in the AIS subgroup. For the source-specific subgrouping strategy, youth were classified as AIS based on mother report (AIS:M) or teacher report (AIS:T). The remaining youth were classified as primarily NS if they met severity criteria for four ODD symptoms, but two or fewer AIS, or Controls (three or fewer ODD symptoms). When mothers' ratings were the basis of group classification, 212 younger (70% male) and 284 older (69% male) youth met symptom criteria for ODD, of whom 53% (n = 112, 63% male) and 64% (n =181, 70% male), respectively, were classified AIS. Remaining youth were Controls (younger cohort: n = 328, 74% male; older cohort: n = 319, 66% male). Using teachers' ratings to construct groups, 204 younger (79% male) and 195 older (77% male) youth were ODD, of whom 61% in each age group (younger cohort: n =125, 82% male; older cohort: n =119, 77% male) were classified AIS. Remaining youth were Controls (younger: n = 333, 69% male; older: n = 396, 63% male).

For the source-exclusive subgrouping strategy, cross-informant youth had to meet criteria for AIS according to both mothers' and teachers' ratings (AIS:M + T; younger cohort: n = 38, 68% male; older cohort: n = 52, 83% male). Informant-exclusive groups were constructed on the basis of one (but not both) informant indicating AIS status: mother only (AIS:M; younger cohort: n = 76, 60% male; older cohort: n = 131, 66% male) and teacher only (AIS:T; younger cohort: n = 89, 89% male; older cohort: n = 68, 74% male). The remaining youth were classified NS (younger cohort: n = 21, 81% male; older cohort: n = 22, 77% male) if they met severity criteria for four ODD symptoms from either informant, but neither informant endorsed more than two AIS symptoms. Youth were classified Controls (younger cohort: n =314, 71% male; older cohort: n =316, 65% male) if they were rated as having three or fewer ODD symptoms from each informant.

2.5. Statistical analyses

We conducted one-way ANOVAs with follow-up LSD tests for significant findings (two-tailed) to localize differences among groups. We used a Bonferroni correction within measure. Effect sizes (eta2) are reported for the main effects and can be interpreted as follows: 0.01 (small), 0.06 (medium), and 0.14 (large; Cohen, 1988).

3. Results

3.1. Source-specific AIS and NS

Mother-defined AIS and NS groups were rated as having more severe ASD and SSD symptoms than Controls (Table 1), with the exception of communication deficits among younger youth (AIS > NS,C). Moreover, younger youth with AIS were rated as having more severe ASD and SSD symptoms than the NS group; however, with two exceptions (ASD social deficits and ASD summary score), this was not the case among older youth.

Table 1.

Means (SDs) and comparison statistics for mothers' ratings of ASD and SSD symptoms in mother-defined (source-specific) ODD subgroups and clinic controls.

Variable Angry/irritable (AIS) Noncompliant (NS) Controls (C) F eta2 Post hoc
Ages 6–11 years n = 112 n = 100 n = 328
ASD
 Communication deficits 2.3 (2.5) 1.7 (2.0) 1.1 (1.8) 14.4*** 0.05 AIS > NS,C
 Social deficits 4.2 (3.3) 2.7 (2.4) 1.4 (2.0) 61.3*** 0.19 AIS > NS > C
 Perseverative behaviors 3.4 (2.5) 2.4 (2.6) 1.4 (1.9) 33.6*** 0.11 AIS > NS > C
 ASD summary score 9.7 (6.6) 6.8 (5.5) 3.9 (4.9) 49.5*** 0.16 AIS > NS > C
Schizophrenia spectrum 6.0 (6.1) 3.3 (4.0) 1.9 (2.8) 45.1*** 0.15 AIS > NS > C

Variable Angry/irritable (AIS) Noncompliant (NS) Controls (C) F eta2 Post hoc
Ages 12–18 years n = 181 n = 103 n = 319
ASD
 Communication deficits 1.9 (1.9) 1.4 (1.6) 0.9 (1.6) 21.9*** 0.07 AIS,NS > C
 Social deficits 3.5 (2.7) 2.7 (2.9) 1.4 (2.0) 46.5*** 0.14 AIS > NS > C
 Perseverative behaviors 2.3 (2.3) 2.0 (2.2) 0.9 (1.5) 35.0*** 0.11 AIS,NS > C
 ASD summary score 7.7 (5.4) 6.1 (5.4) 3.2 (4.3) 52.4*** 0.15 AIS > NS > C
Schizophrenia spectrum 5.9 (5.3) 4.9 (4.3) 2.5 (3.3) 42.6*** 0.13 AIS,NS > C

Note: ASD, autism spectrum disorder; SSD, schizophrenia spectrum disorder; ODD, oppositional defiant disorder; eta2, effect size.

***

p < .001.

Teacher-defined AIS and NS groups were rated as having more severe ASD and SSD symptoms than Controls (Table 2). However, unlike mother-defined groups, younger teacher-defined AIS and NS groups evidenced comparable levels of symptom severity, with the exception of SSD (AIS > NS). Among older youth, the AIS and NS groups did not differ from each other for any of the ASD and SSD variables.

Table 2.

Means (SDs) and comparison statistics for teachers' ratings of ASD and SSD symptoms in teacher-defined (source-specific) ODD subgroups and clinic controls.

Variable Angry/irritable (AIS) Noncompliant (NS) Controls (C) F eta2 Post hoc
Ages 6–11 years n = 125 n = 79 n = 333
ASD
 Communication deficits 3.0 (2.6) 3.1 (2.8) 1.6 (2.4) 20.5*** 0.07 AIS,NS > C
 Social deficits 6.1 (3.5) 5.8 (3.2) 2.7 (3.1) 65.1*** 0.20 AIS,NS > C
 Perseverative behaviors 3.6 (3.2) 2.8 (2.6) 1.5 (2.3) 34.3*** 0.11 AIS,NS > C
 ASD summary score 12.7 (7.5) 11.6 (6.9) 5.7 (6.5) 56.6*** 0.18 AIS,NS > C
Schizophrenia spectrum 8.3 (7.9) 6.5 (7.0) 3.6 (5.0) 29.1*** 0.10 AIS > NS > C

Variable Angry/irritable (AIS) Noncompliant (NS) Controls (C) F eta2 Post hoc
Ages 12–18 years n = 119 n = 76 n = 396
ASD
 Communication deficits 2.2 (2.5) 1.9 (2.0) 1.0 (1.7) 20.8*** 0.07 AIS,NS > C
 Social deficits 5.1 (3.3) 4.3 (3.1) 2.3 (2.8) 49.9*** 0.15 AIS,NS > C
 Perseverative behaviors 2.7 (2.8) 2.3 (2.4) 0.8 (1.6) 48.4*** 0.14 AIS,NS > C
 ASD summary score 10.0 (7.6) 8.5 (6.2) 4.1 (5.0) 53.8*** 0.16 AIS,NS > C
Schizophrenia spectrum 6.5 (6.7) 5.1 (6.2) 3.3 (4.6) 16.8*** 0.06 AIS,NS > C

Note: ASD, autism spectrum disorder; SSD, schizophrenia spectrum disorder; ODD, oppositional defiant disorder; eta2, effect size.

***

p < .001.

3.2. Source-exclusive and cross-informant AIS

Mothers' ratings did not support the notion that cross-informant AIS was associated with more severe ASD and SSD symptoms than source-exclusive AIS:M (Table 3). However, in most instances the two source-exclusive groups were different from each other in a manner consistent with the informant whose ratings were used to define ASD and SSD (AIS:M > AIS:T). Moreover, the AIS:T group was generally comparable to Controls. The NS group was rated as having more severe symptoms than Controls for several variables including SSD symptoms (both younger and older youth). The NS group also differed from AIS groups for perseverative behaviors (AIS:M + T > NS, younger cohort) and SSD symptoms (AIS:M > NS, younger cohort; NS > ASI:T, older cohort).

Table 3.

Means (SDs) and comparison statistics for mothers' ratings of co-occurring ASD and SSD symptoms in mother- and teacher-defined source-exclusive, anger/irritability symptom (AIS) subgroups, cross-informant AIS, children with noncompliant symptoms (NS), and clinic controls.

Variable AIS-M AIS-T AIS-M + T NS Controls (C) F eta2 Post hoc
Ages 6–11 years n = 76 n = 89 n = 38 n = 21 n = 314
ASD
 Communication deficits 2.5 (2.6) 1.5 (1.9) 1.8 (2.1) 2.0 (2.4) 1.2 (1.9) 7.0*** 0.05 M > T,C
 Social deficits 4.3 (3.3) 2.1 (2.3) 4.1 (3.4) 3.2 (2.6) 1.5 (2.1) 27.7*** 0.17 M + T,M > T > C; NS > C
 Perseverative behaviors 3.1 (2.0) 2.2 (2.4) 3.8 (3.2) 2.5 (2.3) 1.5 (2.0) 16.0*** 0.11 M + T,M > T,C; M + T > NS > C
 ASD summary score 9.7 (6.3) 5.8 (5.3) 9.7 (7.3) 7.7 (5.7) 4.1 (5.0) 22.0*** 0.14 M + T,M > T,C
Schizophrenia spectrum 6.1 (6.1) 2.5 (3.3) 5.7 (6.2) 4.6 (1.0) 2.0 (3.0) 20.7*** 0.14 M + T,M > T,C; M > NS > C

Variable AIS-M AIS-T AIS-M + T NS Controls (C) F eta2 Post hoc
Ages 12–18 years n = 131 n = 68 n = 52 n = 22 n = 316
ASD
 Communication deficits 1.7 (1.8) 1.1 (1.3) 2.5 (2.2) 1.3 (1.4) 1.0 (1.7) 10.7*** 0.07 M + T,M > C; M + T > T
 Social deficits 3.3 (2.8) 1.8 (2.1) 3.8 (2.7) 2.6 (2.9) 1.7 (2.3) 15.9*** 0.10 M + T,M > T,C
 Perseverative behaviors 2.1 (2.4) 1.3 (1.6) 3.0 (2.5) 2.3 (2.4) 1.1 (1.6) 14.8*** 0.09 M + T,M > C; M + T > T
 ASD summary score 7.0 (5.5) 4.0 (4.2) 9.2 (6.1) 6.3 (5.3) 3.7 (4.6) 20.8*** 0.13 M + T,M > T,C
Schizophrenia spectrum 5.7 (5.6) 2.6 (3.0) 6.3 (4.9) 5.0 (4.7) 3.0 (3.7) 15.2*** 0.10 M + T,M,NS > T,C

Note: ASD, autism spectrum disorder; SSD, schizophrenia spectrum disorder; M, mother; T, teacher; eta2, effect size.

***

p < .001.

Teachers' ratings evidenced a generally similar pattern of group differences as mothers' ratings, with the notable exception that younger children in the AIS:T group had more severe communication deficits and ASD summary scores than the cross-informant (AIS:M + T) group (Table 4). However, older AIS:M + T and AIS:T youth were rated similarly. In all but one instance (SSD symptoms, older youth), the two source-exclusive groups were different from each other in a manner consistent with the informant whose ratings were used to define ASD and SSD (AIS:T > AIS:M). Symptom severity scores for the AIS:M group were generally comparable to Controls. Among the younger cohort, the NS group differed from source-exclusive AIS groups for social deficits (AIS:T > NS) and perseverative behaviors (NS > AIS:M).

Table 4.

Means (SDs) and comparison statistics for teachers' ratings of co-occurring ASD and SSD symptoms in mother- and teacher-defined source-exclusive, anger/irritability symptom (AIS) subgroups, cross-informant AIS, children with noncompliant symptoms (NS), and clinic controls.

Variable AIS-M AIS-T AIS-M + T NS Controls (C) F eta2 Post hoc
Ages 6–11 years n = 76 n = 89 n = 38 n = 21 n = 314
ASD
 Communication deficits 1.7 (2.2) 3.6 (2.7) 1.6 (1.8) 2.0 (2.0) 2.0 (2.6) 9.2*** 0.07 T > M + T,M,C
 Social deficits 3.6 (3.3) 6.4 (3.3) 5.4 (3.7) 4.6 (2.9) 3.1 (3.3) 19.0*** 0.13 M + T,T > M,C; T > NS
 Perseverative behaviors 1.6 (2.2) 3.9 (3.3) 3.0 (2.8) 3.1 (2.8) 1.7 (2.4) 15.0*** 0.10 M + T,T,NS > M,C
 ASD summary score 6.7 (6.3) 13.9 (7.4) 9.9 (6.1) 9.9 (6.1) 6.7 (7.2) 19.3*** 0.13 T > M,C
Schizophrenia spectrum 3.3 (4.4) 8.9 (8.1) 7.0 (7.4) 6.0 (6.3) 4.2 (5.8) 12.1*** 0.09 M + T,T > M,C

Variable AIS-M AIS-T AIS-M + T NS Controls (C) F eta2 Post hoc
Ages 12–18 years n = 131 n = 68 n = 52 n = 22 n = 316
ASD
 Communication deficits 1.1 (1.7) 2.3 (2.6) 2.1 (2.4) 1.5 (1.8) 1.2 (1.9) 7.0*** 0.05 M + T,T > M,C
 Social deficits 2.7 (3.0) 5.0 (3.0) 5.1 (3.6) 3.8 (2.7) 2.5 (2.9) 16.9*** 0.11 M + T,T > M,C
 Perseverative behaviors 1.2 (2.1) 2.5 (2.8) 2.7 (2.8) 2.0 (1.8) 1.0 (1.7) 15.2*** 0.10 M + T,T > M,C; NS > C
 ASD summary score 4.9 (5.6) 9.7 (7.2) 9.9 (8.0) 7.3 (5.6) 4.5 (5.4) 17.3*** 0.11 M + T,T > M,C
Schizophrenia spectrum 3.7 (5.0) 6.2 (6.8) 6.6 (6.6) 4.7 (4.8) 3.5 (4.9) 6.5*** 0.04 M + T > M,C

Note: ASD, autism spectrum disorder; SSD, schizophrenia spectrum disorder; M, mother; T, teacher; eta2, effect size.

***

p < .001.

4. Discussion

Although the ASD literature is replete with research about emotion recognition and findings are mixed (e.g., Jones et al., 2011), relatively less is known about emotion dysregulation with the notable exception of anxiety (reviewed by White, Oswald, Ollendick, & Scahill, 2009). This is curious as many youth with ASD who are referred for clinic or school evaluations experience intense emotional reactions (e.g., anger, irritability), and these reactions play an important role in referral for pharmacotherapy, isolation from peers, parental stress, and family distress. Nevertheless, their co-occurrence raises questions as to whether they are epiphenomena of the ASD clinical phenotype, clinical features of a distinct subtype of ASD, or pathogenically similar to phenomena in non-ASD samples. Evidence of an association between emotion dysregulation and ASD symptomatology in non-ASD referrals suggests shared risk factors, supports dimensional models of symptom behaviors (Barneveld et al., 2011; Drabick, 2009), and underscores the potential value of pursuing similar pathogenic models in youth with ASD. The results of the present study indicate many clinically referred, non-ASD youth with ODD (AIS and NS) exhibit elevated symptoms of ASD and SSD compared with Controls (Prediction 1), and this appears to be the case regardless of age, informant, or source-specific versus source-exclusive comparisons, with one notable exception (i.e., mother-rated communication deficits among younger youth, Table 1). Consistent with the procedure for constructing ODD symptom groups, source-exclusive AIS differed from Controls (who according to both informants had few ODD symptoms) only when the same informant's ratings served as the basis for defining AIS group and ASD and SSD symptom severity (Tables 3 and 4). The extant literature and our reported findings indicate that the emotion dysregulation and interpersonal conflicts that define ODD, to include peer conflicts (Drabick & Gadow, 2012; Gadow & Drabick, submitted for publication), may share similarities with communication and social skills deficits of ASD and SSD; indeed, perhaps the most salient similarity is that social interactions are challenging and thus generate a range of intense emotional reactions. It is also possible that ASD and SSD represent divergent extremes of similar processes (Crespi & Badcock, 2008; Russell-Smith, Maybery, & Bayliss, 2010). Our expectation that source-specific symptom groups based on teachers' (Table 2) versus mothers' (Table 1) ratings would reveal more pronounced group differentiation (AIS, NS, Controls) was not supported (Prediction 4). Indeed, differences between AIS and NS groups were observed more frequently among mother-defined groups (AIS > NS for 7 of 10 comparisons; Table 1) than teacher-defined groups (AIS > NS for 1 of 10 comparisons; Table 2). Consistent with this pattern, there was a slightly greater number of group differences for mothers' (Table 3) versus teachers' (Table 4) ratings of source-exclusive groups compared to cross-informant groups.

4.1. Differential validity of AIS and NS (Prediction 2)

Consistent with our expectation that emotion dysregulation (i.e., anger, irritability) would share more commonality with ASD than NS, within-informant group comparisons indicated youth with source-specific AIS had more severe ASD and SSD symptoms than the source-specific NS groups, but this was the case only for mothers' ratings of younger children, mother's ratings of social deficits in older youth (Table 1), and teachers' ratings of SSD in younger children (Table 2). Nevertheless, these results provide additional support for the notion that AIS and NS represent divergent phenomena in non-ASD clinically referred youth, and extend this observation to ASD and SSD symptoms. Although the AIS and NS dichotomy is sometimes referred to as the affective and behavioral aspects of ODD, respectively (Burke & Loeber, 2010), it is possible that these symptom groups pertain to different types of affect with unique neurobiologic substrates and phylogenetic histories (e.g., NS may be more associated with novelty-seeking/exploratory behaviors; Alcaro, Huber, & Panksepp, 2007; Drabick & Gadow, 2012).

4.2. Similarities between ASD and SSD (Prediction 3)

In general, both ASD and SSD symptoms evidenced a similar pattern of source-specific (Tables 1 and 2) and source-exclusive group differences (Tables 3 and 4), which was not unexpected as both symptom domains appear to be interrelated (Gadow & DeVincent, 2012). We are mindful of the extraordinary conceptual issues surrounding the differential validity of ASD and SSD symptoms (see Starling & Dossetor, 2009) and would simply add that some questions may not be resolvable with our current nosology. For example, a youth who is cognitively rigid and consequently encounters difficulties complying with authority figures and getting along with peers would exhibit at least one symptom of ASD, but would likely be classified as ODD in everyday clinical settings. Our current categorical nosology may not be well-equipped to address these issues (e.g., Crespi, 2010; Meyer-Lindberg, 2010; Panksepp, 2006), including difficulty with differential diagnosis, informant perceptions, and use of multiple informants (Drabick, 2009; Gadow & DeVincent, 2012).

4.3. Behavioral variation and informant discrepancies (Prediction 5)

For decades, investigators have reported modest levels of agreement between different informants' ratings of child psychopathology, which is illustrated by the findings of an influential meta-analysis conducted by Achenbach, McConaughy, and Howell (1987) who examined inter-rater correlations from 119 studies. They found the average correlation between parents' and teachers' ratings of child behavior was low (r = .27). Although there has been a long-standing tendency to dismiss the significance of informant differences as being “measurement error” or “methodological nuisances” (see De Los Reyes, 2011), findings of studies conducted in multiple countries have found differences in the environmental, biological, and behavioral concomitants of cross-situational, source-specific, and source-exclusive ODD (e.g., Dirks et al., 2011; Drabick & Gadow, 2012; Drabick et al., 2007, 2008, 2011; Gadow & Nolan, 2002; Gadow, DeVincent, & Drabick, 2008; Gadow, Chernoff, et al., 2010; Munkvold, Lundervold, Lie, & Manger, 2009; Offord et al., 1996; Severa, Lorenzo-Seva, Cardo, Rodríguez-Fornells, & Burns, 2010; Wood, Rijsdijk, Asherson, & Kuntsi, 2009) and between mothers' and teachers' perceptions of therapeutic improvement in ODD symptoms consequent to intervention (e.g., Gadow, Nolan, Sverd, Sprafkin, & Schneider, 2008). As we have discussed elsewhere (Gadow & Drabick, submitted for publication), these source-exclusive groups differ in a wide range of background characteristics and school-functioning variables, some of which (e.g., parental discipline, failure to do school work) are likely behavioral antecedents of or triggers for intense emotional reactions among youth with AIS.

Variation in behavioral, physiological, and morphological characteristics (traits) in response to different environmental variables (phenotypic plasticity) is a fundamental concept in evolutionary biology and a pervasive feature of life on this planet (Piersma & van Gils, 2010) and plays an important role in human health and disease (e.g., Hochberg et al., 2011). It can be either reversible or permanent and provides a conceptual model for understanding informant discrepancy. A child can behave very differently in different settings (intra-individual variation), and children vary in their ability to modulate their own behavior according to the demands of the situation (inter-individual variation). Reversible, intra-individual differences in behaviors modulated by environmental variables (phenotypic flexibility or behavioral plasticity) can be highly stable in specific environments and show little correlation with behaviors in different settings (context specific) (e.g., Komers, 1997; Piersma & Drent, 2003; Wilson, 1998). A parallel concept (developmental plasticity) applies to irreversible, inter-individual variation in traits resulting from gene × environment interactions during developmental periods. In other words, developmental plasticity refers to an organism's ability to adjust its developmental trajectory in response to environmental cues. Both phenomena apply to child neurobehavioral syndromes and are probably best illustrated in the case of ADHD (which is highly co-morbid with both ODD and ASD (Gadow et al., 2006; Gadow, DeVincent, & Drabick, 2008)) simply because it is the most common child psychiatric disorder and consequently the most studied.

Many children with ADHD evidence dramatic within-individual changes in behavior depending on contextual features (e.g., task demands, novelty, level of structure, adult presence), illustrated by compliant behavior when in the physician's office (Sleator, 1982). Behavioral plasticity among children with ADHD is also evident in response to different activities within the same school setting (e.g., Whalen et al., 1978; Zentall & Zentall, 1975). Moreover, their reactions to environmental variation evidence between-individual variation compared with typically developing peers without ADHD (e.g., Porrino et al., 1983). Consistent with these observations, there is growing evidence suggesting that common genetic polymorphisms interact with environmental factors to influence within- and between-individual differences in behavioral plasticity (e.g., Bakermans-Kranenburg & vanIJzendoorn, 2007; Belsky et al., 2009; Dmitrieva, Chen, Greenberger, Ogunseitan, & Ding, 2010; Martel et al., 2011; Reiner & Spangler, 2010).

Our research extends this line of inquiry to inter-individual variation within the ODD clinical phenotype by comparing children who were seemingly less behaviorally plastic in terms of emotion regulation (i.e., youth who were rated as having AIS according to both mothers and teachers) with peers who appeared to be more plastic (i.e., exhibited AIS according to only one informant) (Tables 3 and 4). Phenotypic flexibility in youth with ADHD (e.g., Marwit & Stenner, 1972), ODD (e.g., Gadow & Drabick, submitted for publication), or AIS is likely mediated at least in part by cognitive and other child-specific variables (e.g., common gene variants; Belsky et al., 2009) that modulate reactions to task demands and contextual features. In summary, from our perspective, informant discrepancy is not only expected but also clinically relevant, and may be explained in part in terms of mechanisms that underlie behavioral plasticity.

4.4. Cross-informant syndromes (Prediction 6)

Our expectation that cross-informant AIS would be associated with more severe ASD and SSD symptoms than source-exclusive AIS was generally not supported with two notable exceptions: (a) teachers' ratings of communication deficits (but not SSD) symptoms among 6–11 year olds (AIS:T > AIS:M + T), and (b) mothers' ratings of the AIS:T group (Table 3) and teachers' ratings of the ASI:M group (Table 4) (i.e., cross-informant ratings of the source-exclusive groups.) The fact that the younger, teacher-exclusive group had more severe ASD symptoms than the cross-informant group suggests a more environmentally sensitive condition. As previously noted, one plausible explanation for the former seemingly counter-intuitive finding is that different pathogenic processes may be linked to the informant or the environment that serves as the informant's frame of reference (e.g., De Los Reyes & Kazdin, 2005; Drabick et al., 2008). For example, communication and social skills play an important role in successful school functioning, and it is therefore not unexpected that children in the teacher-exclusive AIS group would obtain higher scores for these symptoms than the AIS:M + T group. This is also consistent with our previous findings of a differentially higher rate of early language problems in these same children with AIS:T (see Gadow & Drabick, submitted for publication).

4.5. Age (Prediction 7)

Consistent with our prediction that younger and older youth would exhibit a different pattern of group differences in SSD severity, informants indicated differences between source-specific AIS and NS groups in younger (AIS > NS > C; Table 1) but not older (AIS,NS > C; Table 2) youth. Interestingly, this same pattern of group differences was obtained for both mothers' and teachers' ratings. There were also age-related differences in findings for source-exclusive groups. Unlike source-specific groups, comparisons for each informant and each age cohort resulted in a unique outcome (Tables 3 and 4), though the cross-sectional design precludes our ability to draw conclusions about developmental differences related to age or informant.

4.6. Strengths and limitations

The present study has several strengths, including an operationalized, dimensional approach to parsing ODD symptoms, based on the recommendations for DSM-5 of an expert consensus panel that reviewed relevant data (Pardini et al., 2010), and assessing ASD and SSD symptoms (Barneveld et al., 2011); a large study sample; consideration of different age groups; and comparison of different informants. Nevertheless, many different biologic, cognitive, and environmental processes can lead to seemingly similar behavioral outcomes (Drabick, 2009), well illustrated by deficits associated with ASD versus SSD (e.g., Crespi & Badcock, 2008; Russell-Smith et al., 2010), and these variables were not considered in the present study. Moreover, although relatively unstudied, it is likely that the social and emotional symptoms that define ODD are pathogenically heterogeneous, and much additional research will be required to understand how they relate to AIS, NS, ASD, and SSD. Given the preponderance of males in the AIS and NS subgroups, we were unable to consider whether patterns of findings differed based on gender. The fact secondary school teachers spend considerably less time with individual students than their colleagues in elementary schools likely impacts opportunities to observe intense emotional reactions by the former.

Information about SSD symptoms (and to some extent ASD symptoms in older youth) are often obtained from self-report (e.g., rating scales, clinical interviews) measures in clinical research, which in the case of SSD may be particularly important for the assessment of positive symptoms such as hallucinations and delusions. Moreover, there is generally poor agreement between parent and youth self-report of psychiatric symptoms (Achenbach et al., 1987; Gadow, Chernoff, et al., 2010). Nevertheless, this does not invalidate mothers' and teachers' ratings of SSD as potentially useful markers of phenotypic heterogeneity or their use in improving understanding of pathogenic processes. For example, poor insight correlates with SSD symptom severity among individuals with adolescent-onset psychosis (Parellada et al., 2009) and ASD is characterized by poor self awareness; therefore, comparisons between younger ASD and non-ASD samples may greatly benefit from the use of caregiver report. Nevertheless, generalization of this study's findings is bounded by assessment and informant considerations.

Age was an important variable in the pattern of diagnostic group differences and though clinically informative, a cross-sectional design cannot address developmental processes. It is reasonable to hypothesize that older youth may represent a somewhat different segment of the clinical population consisting of both early-onset cases with protracted difficulties refractory to caregiver efforts or environmental modifications, as well as youth with recent-onset disturbances modulated in part by different biological process. It would be important to learn whether co-occurring ASD or SSD symptoms in youth with AIS or NS are risk factors for later mental health concerns, and in the case of SSD, whether these relations are similar in ASD and nonASD samples.

Finally, we did not collect information about setting-specific (e.g., individual freedom to chose activity, peer or sibling behaviors, empathy, demands on working memory) or important child-specific (e.g., sensitivity to reward, planning abilities, emotion recognition) variables that may induce or exacerbate intense emotional responses or youth's ability to regulate their reactions. Additional research will be required to determine their role as potential mediators of ODD symptom mechanisms and ASD/SSD processes.

4.7. Clinical and research implications

Owing to the inevitable overlap among youth classified as source-specific versus source-exclusive, it was not possible to test which strategy was superior; however, a more reasonable objective is to determine under what circumstances a particular strategy may be more useful. We illustrate this situation with the following example: in the case of short-acting stimulant medication, it could be argued that if problem behaviors occur primarily in the home (or school), then the evaluation of treatment effects may be better served with parents' (or teachers') assessments, and treatment could be administered in such a way as to address the most problematic setting. Thus, the classification strategy resulting in the greatest degree of phenotypic homogeneity for the purposes of a specific application (e.g., intervention, determination of course) would likely be the most ideal. Unfortunately, in research settings, this may encourage consideration of data from one informant only, which consequently undermines the study of informant discrepancies.

A related issue pertains to qualitative differences in information obtained from different informants. For example, mothers observe child behavior in a much wider range of settings (within-child) than teachers, which is often interpreted to mean their observations are more clinically valid because they capture the youth's “true” behavior. Conversely, a case can be made for the advantages of teachers' ratings as the school provides a standard setting with a restricted range of environmental experiences with many peers and is therefore better able to illuminate individual differences (between child). Moreover, teachers share fewer similarities in genetic background and environmental experiences with their pupils than parents, which is important given the reciprocal nature of social interactions. In view of this complexity, it is truly impressive that any scientific progress is made in understanding emotional responses in children with the aid of conventional assessment instruments.

Proscriptions for action in clinical and research settings are conflicted. In clinical applications, obtaining information from multiple informants, particularly diagnostic evaluations and response to pharmacotherapy, has been advocated for several decades. In clinical research settings, things are a bit muddled. As previously noted, informant discrepancies are often considered a nuisance for many reasons (including an obstacle to publication success; De Los Reyes, 2011). Nevertheless, we would encourage other investigators to examine informant discrepancies with the goal of generating a better understanding of etiology, response to intervention, and predictors of long-term outcome.

As previously discussed (Gadow et al., 2004), informant discrepancy has considerable significance for the interpretation and conduct of clinical research because investigators have generally used the findings of structured interviews with the primary caregiver to construct clinical phenotypes, occasionally conducting similar interviews with the youth. In parallel fashion, many psychologists and school-based investigators have relied heavily on information obtained from the youth's teacher to address inter-individual differences. More recently researchers have incorporated information obtained from multiple informants (i.e., the “or rule”) to define clinical constructs. As the results of the present study indicate, however, these different strategies for defining clinical phenotypes may lead to very different conclusions about similarities and differences between diagnoses and inferences about the magnitude of therapeutic improvement.

Acknowledgments

Dr. Gadow is with the Department of Psychiatry and Behavioral Sciences, Stony Brook University, Stony Brook; Dr. Drabick is with the Department of Psychology, Temple University, Philadelphia. The preparation of this manuscript was supported in part by NIMH 1K01MH073717-01A2 awarded to Dr. Drabick.

Footnotes

Conflicts of interest: Dr. Gadow is shareholder in Checkmate Plus, publisher of the Child and Adolescent Symptom Inventory-4R; Dr. Drabick has no conflict of interest.

Contributor Information

Kenneth D. Gadow, Email: kenneth.gadow@stonybrook.edu.

Deborah A.G. Drabick, Email: ddrabick@temple.edu.

References

  1. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychological Bulletin. 1987;101:213–232. [PubMed] [Google Scholar]
  2. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective. Brain Research Reviews. 2007;56:283–321. doi: 10.1016/j.brainresrev.2007.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV) 4th. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
  4. Bakermans-Kranenburg MJ, vanIJzendoorn MH. Research review: Genetic vulnerability or differential susceptibility in child development: The case of attachment. Journal of Child Psychology and Psychiatry. 2007;48:1160–1173. doi: 10.1111/j.1469-7610.2007.01801.x. [DOI] [PubMed] [Google Scholar]
  5. Barneveld PS, Pieterse J, de Sonneville L, van Rijn S, Lahuis B, van Engeland H, et al. Overlap of autistic and schizotypal traits in adolescents with autism spectrum disorders. Schizophrenia Research. 2011;126:231–236. doi: 10.1016/j.schres.2010.09.004. [DOI] [PubMed] [Google Scholar]
  6. Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R. Vulnerability genes or plasticity genes. Molecular Psychiatry. 2009;14:746–754. doi: 10.1038/mp.2009.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burke JD, Hipwell AE, Loeber R. Dimensions of oppositional defiant disorder as predictors of depression and conduct disorder in preadolescent girls. Journal of the American Academy of Child and Adolescent Psychiatry. 2010;49:484–492. doi: 10.1097/00004583-201005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burke J, Loeber R. Oppositional defiant disorder and the explanation of the comorbidity between behavioral disorders and depression. Clinical Psychology: Science and Practice. 2010;17:319–326. [Google Scholar]
  9. Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, et al. Autistic disorders and schizophrenia: Related or remote? An anatomical likelihood estimation. PLoSONE. 2010;5:e12233. doi: 10.1371/journal.pone.0012233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohen J. Statistical power analysis for the behavioral sciences. 2nd. Mahwah, NJ: Lawrence Erlbaum; 1988. [Google Scholar]
  11. Constantino JN, Todd RD. Autistic traits in the general population. Archives of General Psychiatry. 2003;60:524–530. doi: 10.1001/archpsyc.60.5.524. [DOI] [PubMed] [Google Scholar]
  12. Crespi BJ. The origins and evolution of genetic disease risk in modern humans. Annals of the New York Academy of Sciences. 2010;1206:80–109. doi: 10.1111/j.1749-6632.2010.05707.x. [DOI] [PubMed] [Google Scholar]
  13. Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behavioral and Brain Sciences. 2008;31:241–261. doi: 10.1017/S0140525X08004214. discussion 261–320. [DOI] [PubMed] [Google Scholar]
  14. Dean K, Stevens H, Mortensen PB, Murray RM, Walsh E, Pedersen CB. Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder. Archives of General Psychiatry. 2010;67:822–829. doi: 10.1001/archgenpsychiatry.2010.86. [DOI] [PubMed] [Google Scholar]
  15. de Bruin EI, Ferdinand RF, Meester S, de Nijs PFA, Verheij F. High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism and Developmental Disorders. 2007;37:877–886. doi: 10.1007/s10803-006-0215-x. [DOI] [PubMed] [Google Scholar]
  16. De Los Reyes A. More than measurement error: Discovering meaning behind informant discrepancies in clinical assessments of children and adolescents. Journal of Clinical Child and Adolescent Psychology. 2011;40:1–9. doi: 10.1080/15374416.2011.533405. [DOI] [PubMed] [Google Scholar]
  17. De Los Reyes A, Kazdin AE. Informant discrepancies in the assessment of childhood psychopathology: A critical review, theoretical framework, and recommendations for further study. Psychological Bulletin. 2005;131:483–509. doi: 10.1037/0033-2909.131.4.483. [DOI] [PubMed] [Google Scholar]
  18. DeVincent CJ, Gadow KD. Relative clinical utility of three Child Symptom Inventory-4 scoring algorithms for differentiating children with autism spectrum disorder versus attention-deficit hyperactivity disorder. Autism Research. 2009;2:312–321. doi: 10.1002/aur.106. [DOI] [PubMed] [Google Scholar]
  19. DeVincent CJ, Gadow KD, Delosh D, Geller L. Sleep disturbance and its relation to DSM-IV psychiatric symptoms in preschool-aged children with pervasive developmental disorder and community controls. Journal of Child Neurology. 2007;22:161–169. doi: 10.1177/0883073807300310. [DOI] [PubMed] [Google Scholar]
  20. Dirks MA, Boyle MH, Georgiades K. Psychological symptoms in youth and later socioeconomic functioning: Do associations vary by informant? Journal of Clinical Child and Adolescent Psychology. 2011;40:10–22. doi: 10.1080/15374416.2011.533403. [DOI] [PubMed] [Google Scholar]
  21. Dmitrieva J, Chen C, Greenberger E, Ogunseitan O, Ding YC. Gender-specific expression of the DRD4 gene on adolescent delinquency, anger, and thrill seeking. Social Cognitive & Affective Neuroscience. 2010;6:82–89. doi: 10.1093/scan/nsq020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Drabick DA. Can a developmental psychopathology perspective facilitate a paradigm shift toward a mixed categorical–dimensional classification system? Clinical Psychology: Science and Practice. 2009;16:41–49. doi: 10.1111/j.1468-2850.2009.01141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Drabick DA, Bubier J, Chen D, Price J, Lanza HI. Source-specific oppositional defiant disorder among inner-city children Prospective prediction moderators. Journal of Clinical Child Adolescent Psychology. 2011;40:23–35. doi: 10.1080/15374416.2011.533401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Drabick DAG, Gadow KD. Deconstructing the oppositional defiant disorder phenotype: Clinic-based evidence for an anger/irritability phenotype. Journal of the American Academy of Child and Adolescent Psychiatry. 2012 doi: 10.1016/j.jaac.2012.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Drabick DAJ, Gadow KD, Loney J. Source-specific oppositional defiant disorder: Comorbidity and risk factors in referred elementary school boys. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:92–101. doi: 10.1097/01.chi.0000242245.00174.90. [DOI] [PubMed] [Google Scholar]
  26. Drabick DA, Gadow KD, Loney J. Co-occurring ODD and GAD symptom groups: Source-specific syndromes and cross-informant comorbidity. Journal of Clinical Child and Adolescent Psychology. 2008;37:314–326. doi: 10.1080/15374410801955862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Faridi K, Pawliuk N, King S, Joober R, Malla AK. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis. Schizophrenia Research. 2009;114:57–63. doi: 10.1016/j.schres.2009.07.007. [DOI] [PubMed] [Google Scholar]
  28. Gadow KD, Chernoff M, Williams PL, Brouwers P, Morse E, Heston J, et al. Co-Occurring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. Journal of Developmental and Behavioral Pediatrics. 2010;31:116–128. doi: 10.1097/DBP.0b013e3181cdaa20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gadow KD, DeVincent CJ. Autism spectrum disorder, impairing schizophrenia spectrum traits, gender, season of birth, and mental health risk factors. Journal of Autism and Developmental Disorders. 2012 doi: 10.1007/s10803-012-1473-4. [DOI] [PubMed] [Google Scholar]
  30. Gadow KD, DeVincent CJ, Drabick DAG. Oppositional defiant disorder as a clinical phenotype in children with autism spectrum disorder. Journal ofAutism and Developmental Disorders. 2008;38:1302–1310. doi: 10.1007/s10803-007-0516-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gadow KD, DeVincent CJ, Olvet DM, Pisarevskaya V, Hatchwell E. Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder, and repetitive behaviors in children with autism spectrum disorder. European Journal of Neuroscience. 2010;32:1058–1065. doi: 10.1111/j.1460-9568.2010.07382.x. [DOI] [PubMed] [Google Scholar]
  32. Gadow KD, DeVincent CJ, Pomeroy J. ADHD symptom subtypes in children with pervasive developmental disorder. Journal of Autism and Developmental Disorders. 2006;36:271–283. doi: 10.1007/s10803-005-0060-3. [DOI] [PubMed] [Google Scholar]
  33. Gadow KD, DeVincent CJ, Pomeroy J, Azizian A. Comparison of DSM-IV symptoms in elementary school-aged children with PDD versus clinic and community samples. Autism. 2005;9:392–415. doi: 10.1177/1362361305056079. [DOI] [PubMed] [Google Scholar]
  34. Gadow KD, DeVincent C, Schneider J. Predictors of psychiatric symptoms in children with an autism spectrum disorder. Journal of Autism and Developmental Disorders. 2008;38:1710–1720. doi: 10.1007/s10803-008-0556-8. [DOI] [PubMed] [Google Scholar]
  35. Gadow KD, DeVincent CJ, Schneider J. Comparative study of children with ADHD Only, autism spectrum disorder + ADHD, and chronic multiple tic disorder + ADHD. Journal of Attention Disorders. 2009;12:474–485. doi: 10.1177/1087054708320404. [DOI] [PubMed] [Google Scholar]
  36. Gadow KD, Drabick DAG. Anger and irritability symptoms in youth with ODD: Cross-informant versus informant-exclusive syndromes. doi: 10.1007/s10802-012-9637-4. submitted for publication. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gadow KD, Drabick DAG, Loney J, Sprafkin J, Salisbury H, Azizian A, et al. Comparison of ADHD symptom subtypes as source-specific syndromes. Journal of Child Psychology and Psychiatry. 2004;45:1135–1149. doi: 10.1111/j.1469-7610.2004.00306.x. [DOI] [PubMed] [Google Scholar]
  38. Gadow KD, Guttmann-Steinmetz S, Rieffe C, DeVincent CJ. Depression symptoms in boys with autism spectrum disorder and comparison samples. Journal of Autism and Developmental Disorders. 2011 doi: 10.1007/s10803-011-1367-x. Published online: 30 September 2011. [DOI] [PubMed] [Google Scholar]
  39. Gadow KD, Nolan EE. Differences between preschool children with ODD, ADHD, and ODD + ADHD symptoms. Journal of Child Psychology and Psychiatry. 2002;43:191–201. doi: 10.1111/1469-7610.00012. [DOI] [PubMed] [Google Scholar]
  40. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J. Methylphenidate in children with oppositional defiant disorder and both co-morbid chronic multiple tic disorder and ADHD. Journal of Child Neurology. 2008;23:981–990. doi: 10.1177/0883073808315412. [DOI] [PubMed] [Google Scholar]
  41. Gadow KD, Schwartz J, DeVincent C, Strong G, Cuva S. Clinical utility of autism spectrum disorder scoring algorithms for the Child Symptom Inventory. Journal of Autism and Developmental Disorders. 2008;38:419–427. doi: 10.1007/s10803-007-0408-y. [DOI] [PubMed] [Google Scholar]
  42. Gadow KD, Sprafkin J. Stony brook child psychiatric checklist-3. Stony Brook: Department of Psychiatry, State University of New York; 1986. [Google Scholar]
  43. Gadow KD, Sprafkin J. Adolescent supplement to the Child Symptom Inventories manual. Stony Brook, NY: Checkmate Plus; 1995. [Google Scholar]
  44. Gadow KD, Sprafkin J. Child Symptom Inventory-4 screening and norms manual. Stony Brook, NY: Checkmate Plus; 2002. [Google Scholar]
  45. Gadow KD, Sprafkin J. Child and adolescent symptom inventory-4R. Stony Brook, NY: Checkmate Plus; 2005. [Google Scholar]
  46. Gadow KD, Sprafkin J. Adolescent symptom inventory-4 screening and norms manual. Stony Brook, NY: Checkmate Plus; 2008. [Google Scholar]
  47. Gadow KD, Sprafkin J. The symptom inventories: An annotated bibliography (online) Stony Brook, NY: Checkmate Plus; 2010. Available: www.checkmateplus.com. [Google Scholar]
  48. Grayson P, Carlson GA. The utility of a DSM-III-R-based checklist in screening child psychiatric patients. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:669–673. doi: 10.1097/00004583-199107000-00021. [DOI] [PubMed] [Google Scholar]
  49. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. Recurrent rearrangements is synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Archives of General Psychiatry. 2009;66:947–956. doi: 10.1001/archgenpsychiatry.2009.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Guttmann-Steinmetz S, Gadow KD, DeVincent CJ, Crowell J. Anxiety symptoms in boys with autism spectrum disorder, attention-deficit hyperactivity disorder, or chronic multiple tic disorder and community controls. Journal of Autism and Developmental Disorders. 2010;40:1006–1016. doi: 10.1007/s10803-010-0950-x. [DOI] [PubMed] [Google Scholar]
  51. Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, et al. Child health, developmental plasticity, and epigenetic programming. Endocrine Reviews. 2011;32:159–224. doi: 10.1210/er.2009-0039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Jones CRG, Pickles A, Falcaro M, Marsden AJS, Happe′ F, Scott SK, et al. A multimodal approach to emotion recognition ability in autism spectrum disorders. Journal of Child Psychology and Psychiatry. 2011;52:275–285. doi: 10.1111/j.1469-7610.2010.02328.x. [DOI] [PubMed] [Google Scholar]
  53. Kelleher I, Jenner JA, Cannon M. Psychotic symptoms in the general population: An evolutionary perspective. British Journal of Psychiatry. 2010;197:167–169. doi: 10.1192/bjp.bp.109.076018. [DOI] [PubMed] [Google Scholar]
  54. Kirley A, Lowe N, Mullins C, McCarron M, Daly G, Waldman I, et al. Phenotype studies of the DRD4 gene polymorphisms in ADHD. American Journal of Medical Genetics Part B. 2004;131B:38–42. doi: 10.1002/ajmg.b.30072. [DOI] [PubMed] [Google Scholar]
  55. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M, et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics. 2008;17:458–465. doi: 10.1093/hmg/ddm323. [DOI] [PubMed] [Google Scholar]
  56. Komers P. Behavioural plasticity in variable environments. Canadian Journal of Zoology. 1997;75:161–169. [Google Scholar]
  57. Kunihira Y, Senju A, Dairoku H, Wakabayashi A, Hasegawa T. Autistic' traits in non-autistic Japanese populations: Relationships with personality traits and cognitive ability. Journal of Autism and Developmental Disorders. 2006;36:553–566. doi: 10.1007/s10803-006-0094-1. [DOI] [PubMed] [Google Scholar]
  58. Lecavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subjective characteristics, and empirical classification. Journal of Autism and Developmental Disorders. 2006;36:1101–1114. doi: 10.1007/s10803-006-0147-5. [DOI] [PubMed] [Google Scholar]
  59. Lecavalier L, Gadow KD, DeVincent CJ, Houts C, Edwards MC. Deconstructing the PDD clinical phenotype: Internal validity of the DSM-IV. Journal of Child Psychology and Psychiatry. 2009;50:1246–1254. doi: 10.1111/j.1469-7610.2009.02104.x. [DOI] [PubMed] [Google Scholar]
  60. Leibenluft E, Cohen P, Gorrindo T, Brook JS, Pine DS. Chronic versus episodic irritability in youth: A community-based, longitudinal study of clinical and diagnostic associations. Journal of Child and Adolescent Psychopharmacology. 2006;16:456–466. doi: 10.1089/cap.2006.16.456. [DOI] [PubMed] [Google Scholar]
  61. Martel MM, Nikolas M, Jernigan K, Friderici K, Waldman I, Nigg JT. The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD. Journal of Abnormal Child Psychology. 2011;39:1–10. doi: 10.1007/s10802-010-9439-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Marwit SJ, Stenner AJ. Hyperkinesis: Delineation of two patterns. Exceptional Children. 1972;38:401–406. doi: 10.1177/001440297203800506. [DOI] [PubMed] [Google Scholar]
  63. Mata I, Sham PC, Gilvarry CM, Jones PB, Lewis SW, Murray RM. Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives. Schizophrenia Research. 2000;44:129–136. doi: 10.1016/S0920-9964(99)00222-4. [DOI] [PubMed] [Google Scholar]
  64. Mattison RE, Gadow KD, Sprafkin J, Nolan EE, Schneider J. A DSM-IV-referenced teacher rating scale for use in clinical management. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:444–449. doi: 10.1097/01.CHI.0000046813.95464.B3. [DOI] [PubMed] [Google Scholar]
  65. Mayes SD, Calhoun SL, Murray MJ, Ahuja M, Smith LA. Anxiety, depression, and irritability in children with autism relative to other neuropsychiatric disorders and typical development. Research in Autism Spectrum Disorders. 2011;5:474–485. [Google Scholar]
  66. Meyer-Lindberg A. Intermediate or brainless phenotypes for psychiatric research? Psychological Medicine. 2010;40:1057–1062. doi: 10.1017/s0033291709991929. [DOI] [PubMed] [Google Scholar]
  67. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, et al. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and or autism spectrum disorders. American Journal of medical Genetics Part A. 2011;155:2386–2396. doi: 10.1002/ajmg.a.34177. [DOI] [PubMed] [Google Scholar]
  68. Mulligan A, Anney RJL, O'Regan M, Chen W, Butler L, Fitzgerald M, et al. Autism symptoms in attention-deficit/hyperactivity disorder: A familial trait which correlates with conduct, oppositional defiant, language, and motor disorders. Journal of Autism and Developmental Disorders. 2009;39:197–209. doi: 10.1007/s10803-008-0621-3. [DOI] [PubMed] [Google Scholar]
  69. Munkvold L, Lundervold A, Lie SA, Manger T. Should there be separate parent and teacher-based categories of ODD? Evidence from a general population. Journal of Child Psychology and Psychiatry. 2009;50:1264–1272. doi: 10.1111/j.1469-7610.2009.02091.x. [DOI] [PubMed] [Google Scholar]
  70. Offord DR, Boyle MH, Racine Y, Szatmari P, Fleming JE, Sanford M, et al. Integrating assessment data from multiple informants. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:1078–1085. doi: 10.1097/00004583-199608000-00019. [DOI] [PubMed] [Google Scholar]
  71. Panksepp J. Emotional endophenotypes in evolutionary psychiatry. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006;30:774–784. doi: 10.1016/j.pnpbp.2006.01.004. [DOI] [PubMed] [Google Scholar]
  72. Pardini DA, Frick PJ, Moffitt TE. Building an evidence base for DSM-5 conceptualizations of oppositional defiant disorder and conduct disorder: Introduction to special section. Journal of Abnormal Psychology. 2010;119:683–688. doi: 10.1037/a0021441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nature Reviews Neuroscience. 2008;9:947–957. doi: 10.1038/nrn2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Piersma T, Drent J. Phenotypic flexibility and the evolution of organismal design. TRENDS in Ecology and Evolution. 2003;18:223–228. [Google Scholar]
  75. Piersma T, van Gils JA. The flexible phenotype: A body-centered integration of ecology, physiology and behaviour. Oxford: Oxford University Press; 2010. [Google Scholar]
  76. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE. A naturalistic assessment of the motor activity of hyperactive boys. Archives of General Psychiatry. 1983;40:681–687. doi: 10.1001/archpsyc.1983.04390010091012. [DOI] [PubMed] [Google Scholar]
  77. Posserud MB, Lundervold AJ, Gillberg C. Autistic features in total population of 7–9-year-old children assessed by the ASSQ (Autism Spectrum Screening Questionnaire) Journal of Child Psychology and Psychiatry. 2006;47:167–175. doi: 10.1111/j.1469-7610.2005.01462.x. [DOI] [PubMed] [Google Scholar]
  78. Reiersen AM, Constantino JN, Volk HE, Todd RD. Autism symptoms in a population-based ADHD twin sample. Journal of Child Psychology and Psychiatry. 2007;48:464–472. doi: 10.1111/j.1469-7610.2006.01720.x. [DOI] [PubMed] [Google Scholar]
  79. Reiner I, Spangler G. Adult attachment and gene polymorphisms of the dopamine D4 receptor and serotonin transporter (5-HTT) Attachment and Human Development. 2010;12:209–229. doi: 10.1080/14616731003759674. [DOI] [PubMed] [Google Scholar]
  80. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. Journal of Child Psychology and Psychiatry. 2008;49:535–542. doi: 10.1111/j.1469-7610.2007.01857.x. [DOI] [PubMed] [Google Scholar]
  81. Rowe R, Costello JE, Angold A, Copeland WE, Maughan B. Developmental pathways in oppositional defiant disorder and conduct disorder. Journal of Abnormal Psychology. 2010;119:726–738. doi: 10.1037/a0020798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Russell-Smith SN, Maybery MT, Bayliss DM. Are the autism and positive schizotypy spectra diametrically opposed in local versus global processing? Journal of Autism and Developmental Disorders. 2010;40:968–977. doi: 10.1007/s10803-010-0945-7. [DOI] [PubMed] [Google Scholar]
  83. Sahoo T, Theisen A, Rosenfeld JA, Lamb AN, Ravnan JB, Schultz RA, et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genetics in Medicine. 2011;13:868–880. doi: 10.1097/GIM.0b013e3182217a06. [DOI] [PubMed] [Google Scholar]
  84. Sanislow CA, Pine DS, Quinn KJ, Kozak MJ, Garvey MA, Heinssen RK, et al. Developing constructs for psychopathology research: Research domain criteria. Journal of Abnormal Psychology. 2010 Oct; doi: 10.1037/a0020909. Advance online publication. [DOI] [PubMed] [Google Scholar]
  85. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: One disorder, multiple mutations; one mutation, multiple disorders. Trends in Genetics. 2009;25:528–535. doi: 10.1016/j.tig.2009.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Severa M, Lorenzo-Seva U, Cardo E, Rodríguez-Fornells A, Burns GL. Understanding trait and sources effects in attention deficit hyperactivity disorder and oppositional defiant disorder rating scales: Mothers', fathers', and teachers' ratings of children from Balearic Islands. Journal of Clinical Child and Adolescent Psychology. 2010;39:1–11. doi: 10.1080/15374410903401187. [DOI] [PubMed] [Google Scholar]
  87. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry. 2008;47:927–929. doi: 10.1097/CHI.0b013e318179964f. [DOI] [PubMed] [Google Scholar]
  88. Sleator EK. Office diagnosis of hyperactivity by the physician. In: Gadow KD, Bialer I, editors. Advances in learning and behavioral disabilities. Vol. 1. Greenwich, CT: JAI Press; 1982. pp. 341–364. [Google Scholar]
  89. Sporn AL, Addington AM, Gogtay N, Ordon˜ez AE, Gornick M, Clasen L, et al. Pervasive developmental disorder and childhood-onset schizophrenia: Comorbid disorder or a phenotypic variant of a very early onset illness. Biological Psychiatry. 2004;55:989–994. doi: 10.1016/j.biopsych.2004.01.019. [DOI] [PubMed] [Google Scholar]
  90. Starling J, Dossetor D. Pervasive developmental disorders and psychosis. Current Psychiatry Reports. 2009;11:190–196. doi: 10.1007/s11920-009-0030-0. [DOI] [PubMed] [Google Scholar]
  91. Stigler KA, McDougle CJ. Pharmacotherapy of irritability in pervasive developmental disorders. Child and Adolescent Psychiatric Clinics of North America. 2008;17:739–752. doi: 10.1016/j.chc.2008.06.002. [DOI] [PubMed] [Google Scholar]
  92. Stringaris A, Goodman R. Longitudinal outcome of youth oppositionality: Irritable, headstrong, and hurtful behaviors have distinctive predictions. Journal of the American Academy of Child and Adolescent Psychiatry. 2009a;48:404–412. doi: 10.1097/CHI.0b013e3181984f30. [DOI] [PubMed] [Google Scholar]
  93. Stringaris A, Goodman R. Three dimensions of oppositionality in youth. Journal of Child Psychology and Psychiatry. 2009b;50:216–223. doi: 10.1111/j.1469-7610.2008.01989.x. [DOI] [PubMed] [Google Scholar]
  94. Sugranyes G, Kyriakopoulos M, Corrigall R, Taylor E, Frangou S. Autism spectrum disorders and schizophrenia: Meta-analysis of the neural correlates of social cognition. PLoS ONE. 2011;6:e25322. doi: 10.1371/journal.pone.0025322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Ulloa RE, Birmaher B, Axelson D, Williamson DE, Brent DA, Ryan ND, et al. Psychosis in a pediatric mood and anxiety disorders clinic: Phenomenology and correlates. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:337–345. doi: 10.1097/00004583-200003000-00016. [DOI] [PubMed] [Google Scholar]
  96. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–543. doi: 10.1126/science.1155174. [DOI] [PubMed] [Google Scholar]
  97. Weisbrot DM, Gadow KD, DeVincent CJ, Pomeroy J. The presentation of anxiety in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 2005;15:477–496. doi: 10.1089/cap.2005.15.477. [DOI] [PubMed] [Google Scholar]
  98. Whalen CK, Collins BE, Henker B, Alkus SR, Adams D, Stapp S. Behavior observations of hyperactive children and methylphenidate (Ritalin) effects in systematically structured classroom environments: Now you see them, now you don't. Journal of Pediatric Psychology. 1978;3:177–184. [Google Scholar]
  99. Whalley HC, O'Connell G, Sussmann JE, Peel A, Stanfield AC, Hayiou-Thomas ME, et al. Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals. American Journal of Medical Genetics Part B. 2011;156:941–948. doi: 10.1002/ajmg.b.31241. [DOI] [PubMed] [Google Scholar]
  100. White SW, Oswald D, Ollendick T, Scahill L. Anxiety inchildren and adolescents with autism spectrum disorders. Clinical Psychology Review. 2009;29:216–229. doi: 10.1016/j.cpr.2009.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Wilson SW. Adaptive individual differences within single populations. Philosophical Transactions of the Royal Society of London. 1998;353:199–205. [Google Scholar]
  102. Witwer AN, Lecavalier L. Validity of comorbid psychiatric disorders in youngsters with autism spectrum disorders. Journal of Physical and Developmental Disabilities. 2010;22:367–380. [Google Scholar]
  103. Wood AC, Rijsdijk F, Asherson P, Kuntsi J. Hyperactive–impulsive symptom scores and oppositional behaviours reflect alternate manifestations of a single liability. Behavior Genetics. 2009;39:447–460. doi: 10.1007/s10519-009-9290-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Zentall SS, Zentall TR. Activity and task performance of hyperactive children as a function of environmental stimulation. Journal of Consulting and Clinical Psychology. 1975;44:693–697. doi: 10.1037//0022-006x.44.5.693. [DOI] [PubMed] [Google Scholar]

RESOURCES